Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) fell 11.8% on Tuesday . The stock traded as low as C$0.15 and last traded at C$0.15. 222,895 shares changed hands during mid-day trading, a decline of 24% from the average session volume of 293,391 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Performance
The company has a market capitalization of C$24.33 million, a PE ratio of -4.63 and a beta of 0.39. The stock’s fifty day simple moving average is C$0.11 and its 200-day simple moving average is C$0.13. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Featured Stories
- Five stocks we like better than VentriPoint Diagnostics
- How to trade penny stocks: A step-by-step guide
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What Investors Need to Know About Upcoming IPOs
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- What is the Dogs of the Dow Strategy? Overview and Examples
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
